Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.
We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Cookie Policy.
